bioRxivCancer BiologyPreprint
Molecular characterization reveals subclasses of 1q gain in intermediate-risk Wilms tumors
I. A. van Belzen, M. van Tuil, S. Badloe, E. Strengman, A. Janse, E. T. Verwiel, D. F. van der Leest, S. de Vos, J. L. Baker-Hernandez, A. Groenendijk, R. de Krijger, H. H. Kerstens, J. Drost, M. M. van den Heuvel-Eibrink, B. B. Tops, F. C. Holstege, P. Kemmeren, J. Y. Hehir-Kwa
Abstract
Chromosomal alterations have recurrently been identified in Wilms tumors (WTs) and some are associated with poor prognosis. Gain of 1q (1q+) is of special interest given its high prevalence and is currently actively studied for its prognostic value. However, the underlying mutational mechanisms and functional effects remain unknown. For 30 primary WTs, we integrated somatic SNVs, CNs and SVs with expression data and distinguished four clusters characterized by affected biological processes: muscle differentiation, immune system, kidney development and proliferation. We identified 1q+ in eight tumors that differ in mutational mechanisms, subsequent rearrangements and genomic contexts. 1q+ tumors were present in all four expression clusters and individual tumors overexpress different genes on 1q. Through integrating CNs, SVs and gene expression, we identified subgroups of 1q+ tumors reflecting differences in the functional effect of 1q gain, indicating that expression data is likely needed for further risk stratification of 1q+ WTs.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2 p.Q177R mutation
M. J. Stevenson, S. K. Phanor, … L. L. O'Brien·bioRxiv·Nov 2, 2022
- Genotype-phenotype correlations and de novo induction of cancer stem cells in Wilms tumor initiation.
N.S. Pop, Daniëlle Koot, … Peter Hohenstein·bioRxiv·Nov 19, 2025
- Subtype-specific Patterns of Evolution and Clinically Relevant Genomic Instability in Wilms Tumour
George D. Cresswell, Tasnim Chagtai, … William Mifsud·bioRxiv·Sep 4, 2024
- Characterization of the continuous transcriptional heterogeneity in Wilms tumors using unsupervised machine learning
Y. Trink, A. Urbach, … T. Kalisky·bioRxiv·Jun 6, 2022
- Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responses
E. Flietner, M. Yu, … J. Zhang·bioRxiv·Aug 21, 2022
- Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin
B. Royer-Pokora, W. Wruck, M. Beier·bioRxiv·Jun 10, 2022